'Secondary endpoints' presentation slideshows

Blood Transfusion Thresholds in Medical Patients with Coronary Artery Disease

Blood Transfusion Thresholds in Medical Patients with Coronary Artery Disease Internal Medicine Resident Grand Rounds December 4, 2001 Alexander Hadley, MD Case Presentation Mr. C is a 56-year-old male who presented to the ED at WFUBMC with several days of severe sub-sternal chest pain.

2.07k views • 78 slides

Blood Transfusion Thresholds in Medical Patients with Coronary Artery Disease

Blood Transfusion Thresholds in Medical Patients with Coronary Artery Disease. Internal Medicine Resident Grand Rounds December 4, 2001 Alexander Hadley, MD. Case Presentation. Mr. C is a 56-year-old male who presented to the ED at WFUBMC with several days of severe sub-sternal chest pain.

1.31k views • 78 slides

1.47k views • 67 slides

Design and analysis of clinical trials

561 views • 42 slides

Squamous Cell NSCLC Are we making progress?

651 views • 42 slides

Treatment Options for Docetaxel refractory patients

Treatment Options for Docetaxel refractory patients. Winston W Tan MD FACP Senior Consultant Hematology/Oncology Genitourinary Oncology Mayo Clinic College of Medicine. Learning Objectives.

624 views • 33 slides

Vascular & Interventional Radiology Unit Department of Radiological Sciences

528 views • 33 slides

Presented By Martine Piccart-Gebhart at 2014 ASCO Annual Meeting

First results from the phase III ALTTO trial (BIG 02-06; NCCTG 063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone (T), their sequence (T?L) or their combination (L + T) in the adjuvant treatment of HER2-positive <br />early breast cancer (EBC).

480 views • 30 slides

G. Fiorentini 1 , C. Aliberti 2 , G. Benea 2 , G. Turrisi 1 , A. Mambrini 3 , I. Marri 2 , M. Tilli 2 .

RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL ASSESSING SURVIVAL AT 3 YEARS OF POLYVINYL ALCOHOL MICROSPHERES PRELOADED WITH IRINOTECAN (DEBIRI) VS. FOLFIRI IN PATIENTS WITH HEPATIC METASTASES FROM COLORECTAL CANCER.

455 views • 26 slides

538 views • 25 slides

Presenter: Otavio Berwanger (MD; PhD) on Behalf of the BRIDGE-ACS Steering Committe

A Multifaceted Intervention to Narrow the Evidence-Based Gap in the Treatment of Acute Coronary Syndromes: THE BRIDGE-ACS TRIAL. Presenter: Otavio Berwanger (MD; PhD) on Behalf of the BRIDGE-ACS Steering Committe . Sponsor: Ministry of Health-Brazil. Conflicts of Interest.

265 views • 24 slides

Implications of lung cancer screening in the new millenia

Implications of lung cancer screening in the new millenia. Andrew R. Haas, MD, PhD Assistant Professor of Medicine Section of Interventional Pulmonary and Thoracic Oncology Perelman School of Medicine of the University of Pennsylvania arhaas@uphs.upenn.edu. Disclosures. None.

347 views • 24 slides

When & How I Use Rotational Atherectomy for Unprotected Left Main Stem PCI: A Personal Experience 2000 - 2006 Joe

Advanced Angioplasty 2007. When & How I Use Rotational Atherectomy for Unprotected Left Main Stem PCI: A Personal Experience 2000 - 2006 Joe Motwani Consultant Cardiologist, Southwest Cardiothoracic Centre (SWCC), Derriford Hospital, Plymouth, Devon, UK.

650 views • 23 slides

Presented at the March 13, 2003 Oncologic Drugs Advisory Committee meeting By Stephen Howell, M.D. Skyepharma, Inc.

331 views • 19 slides

Phase-III Studie: HECTOR Topotecan plus Carboplatin (Paclitaxel plus Carboplatin oder Gemcitabin plus Carboplatin)

AGO-Austria. Phase-III Studie: HECTOR Topotecan plus Carboplatin (Paclitaxel plus Carboplatin oder Gemcitabin plus Carboplatin) Intergroup Study of NOGGO und Studiengruppe Ovar (NOGGO-R9, AGO Ovar 2.12) AGO-Austria, GEICO.

387 views • 17 slides

Capturing primary endpoints under MTN-016 Version 2.0

Capturing primary endpoints under MTN-016 Version 2.0. Lisa Noguchi, CNM, MSN February 24, 2014 Microbicide Trials Network Annual Meeting Bethesda, MD. Protocol. Version 2.0 distributed to sites on 2/14/2014 Updates aims Deletes product-specific language Omits developmental assessment

238 views • 10 slides

Richardson PG et al. Proc ASH 2012; Abstract 727.

MM-005: A Phase 1, Multicenter, Open-Label, Dose-Escalation Study to Determine the Maximum Tolerated Dose for the Combination of Pomalidomide, Bortezomib, and Low-Dose Dexamethasone in Patients with Relapsed or Relapsed/Refractory Multiple Myeloma. Richardson PG et al.

234 views • 10 slides

RAAVE

Rosuvastatin Affecting Aortic Valve Endothelium to Slow the Progressions of Aortic Stenosis: RAAVE. RAAVE.

252 views • 9 slides

Limbs International Medical Buflomedil Trial

LIMB. Limbs International Medical Buflomedil Trial. Presented at American College of Cardiology Scientific Sessions 2005 Presented by Dr. Alain Leizorovicz. LIMB.

201 views • 7 slides

Introduction

No. 037. A randomised single-blind comparison of the effectiveness of the high-level disinfectants Tristel Fuse (chlorine dioxide) and Cidex OPA ( ortho -phthaldehyde) for use with flexible cystoscopes.

149 views • 1 slides